Parent Quality of Life at Two Years Following Their Child's Completion of Acute Lymphoblastic Leukemia Treatment
Pediatric Blood & Cancer · 2026-06 · 73 (6)
DOI: 10.1002/1545-5017.70248 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 17.03.2026. Verfasst von Sara Dal Pra und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Psychological Sciences, Turner Institute for Brain and Mental Health, Monash University, Clayton, Victoria, Australia. Hauptthemen laut MEDLINE: Precursor Cell Lymphoblastic Leukemia-Lymphoma, Quality of Life, Parents. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The Monash Children's Foundation, The Miranda Foundation, The Leukemia Foundation.
Abstract (Originalsprache)
Background
Parents of children treated for acute lymphoblastic leukemia (ALL) often experience significant caregiver burden and disruption to their well‐being. While parent quality of life (QoL) during treatment is well characterized, little is known about outcomes during early survivorship. This study aimed to (1) compare QoL among patient parents and parents of healthy children at 27 months post‐treatment and (2) examine predictors assessed at 3 months post‐treatment. Procedure Study participants were 83 patient parents and 53 parents of healthy peers from the longitudinal ALLaboard study. Parent QoL was assessed at 27 months utilizing a validated QoL self‐report measure. Predictors of QoL examined included demographic, treatment, parent psychological, and child behavioral factors at the end of treatment. Group differences were examined using paired t‐tests and hierarchical regressions.
Results
Patient parents reported significantly lower psychological, social, and environmental QoL, with environmental QoL most severely impaired. No difference was observed in physical QoL. Parental distress at 3 months predicted poorer psychological, social, and environmental QoL at 27‐months (β = −0.28 to −0.40), while child internalizing behaviors predicted poorer physical QoL (β = −0.36). Older parental age predicted better social QoL (β = 0.32). Treatment intensity was not associated with QoL outcomes.
Conclusions
Parents of patients treated for ALL experience persistent QoL difficulties during the early survivorship period following treatment completion. Elevated parental distress and child internalizing behaviors at the end of treatment are risk factors for poorer outcomes, demonstrating bidirectional parent–child relationships. Early survivorship programs should incorporate systematic, family‐level psychosocial screening at treatment completion and family‐focused interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Psychological Sciences, Turner Institute for Brain and Mental Health, Monash University, Clayton, Victoria, Australia.
- Children's Cancer Centre, The Royal Children's Hospital, Melbourne, Victoria, Australia.
- Clinical Sciences, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
- Department of Paediatrics, University of Melbourne, Victoria, Australia.
Förderung
- The Monash Children's Foundation
- The Miranda Foundation
- The Leukemia Foundation
- The Victorian Comprehensive Cancer Centre
- The Royal Children's Hospital Foundation
- Operational Infrastructure Support Program
- Victorian Cancer Agency
Zitieren
APA
Dal Pra, S., McCarthy, M., Takagi, M., & De Luca, C. (2026). Parent Quality of Life at Two Years Following Their Child's Completion of Acute Lymphoblastic Leukemia Treatment. Pediatric Blood & Cancer, 73(6). https://doi.org/10.1002/1545-5017.70248
Vancouver
Dal Pra S, McCarthy M, Takagi M, De Luca C. Parent Quality of Life at Two Years Following Their Child's Completion of Acute Lymphoblastic Leukemia Treatment. Pediatric Blood & Cancer. 2026;73(6). doi:10.1002/1545-5017.70248
BibTeX
@article{DalPra2026,
author = {Dal Pra, Sara and McCarthy, Maria and Takagi, Michael and De Luca, Cinzia},
title = {Parent Quality of Life at Two Years Following Their Child's Completion of Acute Lymphoblastic Leukemia Treatment},
journal = {Pediatric Blood & Cancer},
year = {2026},
volume = {73},
number = {6},
doi = {10.1002/1545-5017.70248}
}
EUVIMED